Rowe, J M <br/><br/>
Treatment of minimal residual disease in myeloid leukemia--the immunotherapeutic options with emphasis on Linomide.  [electronic resource] 

 -  Leukemia & lymphoma  Nov 1993 
 - 321-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1042-8194 
<br/><br/><label>Standard No.: </label>10.3109/10428199309067922  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--therapeutic use<br/>Humans<br/>Hydroxyquinolines--therapeutic use<br/>Immunotherapy<br/>Interferons--therapeutic use<br/>Interleukin-2--therapeutic use<br/>Killer Cells, Natural--immunology<br/>Leukemia, Myeloid--drug therapy<br/>T-Lymphocytes--immunology